SyncoZymes (Shanghai) Co., Ltd. is founded in 2007 and located in southern district of Shanghai Pudong Zhangjiang High-tech Park, the International Medical Park. SyncoZymes (Shanghai) is a subsidiary company of SyncoZymes (Zhejiang) Co., Ltd. SyncoZymes is committed to the research and development of cutting-edge technologies and products in the field of green pharmaceuticals, leading the development of the chemical pharmaceutical industry with green biotechnology, and providing high-quality products and services to the customers of pharmaceutical and healthy industry.
40Enzyme Systems +
Large Enzyme Library open to customer
Annual Capacity of Enzymes and Coenzymes
EnzymesSyncoZymes has a large enzyme library with 40 series and more than 10,000 enzymes, which can be applied to various types of chemical transformation reactions. Each type of enzyme can be made into enzyme plate for high-throughput screening. The company provides enzyme plate screening services, as well as the development of enzymes for biotransformation, the design and optimization of biotransformation processes, and the transfer of strains.More +
Co-enzymesSyncoZymes supplies co-enzyme of NAD series products, including NMN, NAD, NADP, NADH, NADPH, with an annual output of 100 tons, is one of the main suppliers of NAD-family coenzyme products in the world.More +
Functional Food Raw MaterialsSyncoZymes uses biocatalysis technology to develop green natural functional food raw materials, and produces them in strict accordance with the pharmaceutical standard system. It continuously explores the effects and mechanisms of natural ingredients on human health, realizes the green manufacturing of natural ingredients and provides scientific, safe and effective health for human beings.More +
Pharmaceutical IntermediatesSyncoZymes has a strong biotechnology platform, chemical technology platform and GMP production system, focusing on the development and application of biological enzymes, focusing on the research and development and production of pharmaceutical intermediates.More +
CRO/CDMO ServicesSyncoZymes has a strong biotechnology platform, chemical technology platform, testing and quality research platform and GMP production system, focusing on the development and application research of biological enzymes, focusing on the research and development and application of green biotechnology pharmaceutical intermediates, APIs, functional food raw materials. At the same time, She provides high-end CRO, CDMO services, testing and quality research services.More +
Testing and Quality Research ServicesSyncoZymes undertakes the management and operation of the R&D public service platform in Shanghai International Medical Park, and can provide testing and quality research services for small molecule drug research and development. SyncoZymes equipped with NMR, LCMS, GCMS, HPLC, GC, protein purification, crystal form detection, preparative chromatography and other instrument.More +
R & D system
Academician of Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, etc.
R & D Team
The R&D team has a total of more than 50 people
With more than 2,000 square meters of laboratories
Independently applied for more than 100 patents
Big News! SyncoZymes (Shanghai) Co., Ltd , The world's first NMN raw material passed FDA NDI certification.
New research in Europe: NMN can improve the antiviral activity of CD8 T cells, a specific immune cell of patients with hepatitis B.
Japanese scientists have found that supplementing NMN can treat retinal dysfunction caused by cardiovascular diseases.
A new stage of the epidemic? Many studies have proved that NMN is helpful to prevent and treat Covid-19.
COVID-19 nemesis? Nature: Ursodeoxycholic acid (UDCA) can prevent Covid-19 infection by inhibiting ACE2 receptor!
Customer service contact information
I want to leave a message: